- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/255 - Salmonella (G)
Patent holdings for IPC class C07K 14/255
Total number of patents in this class: 200
10-year publication summary
|
15
|
19
|
19
|
16
|
16
|
24
|
14
|
4
|
15
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Katholieke Universiteit Leuven | 1190 |
8 |
| The Cleveland Clinic Foundation | 1570 |
7 |
| Cleveland BioLabs, Inc. | 19 |
7 |
| Industry Foundation of Chonnam National University | 649 |
6 |
| The Regents of the University of California | 19929 |
5 |
| Prokarium Limited | 31 |
5 |
| University of Kansas | 873 |
5 |
| University of Maryland, Baltimore | 1020 |
5 |
| VaxInnate Corporation | 18 |
5 |
| Emory University | 1629 |
4 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3366 |
4 |
| University of Massachusetts | 2227 |
4 |
| Georgia Tech Research Corporation | 2736 |
3 |
| The Board of Regents for Oklahoma State University | 156 |
3 |
| Eth Zurich | 1275 |
3 |
| Institut Pasteur de Lille | 174 |
3 |
| Nomad Bioscience GmbH | 44 |
3 |
| Regents of the University of Minnesota | 2694 |
3 |
| Bavarian Nordic A/S | 257 |
3 |
| The General Hospital Corporation | 4731 |
2 |
| Other owners | 112 |